课题基金 / 基金详情

NHLBI DNA Re-sequencing and Genotyping Program

NHLBI DNA Re-sequencing and Genotyping Program
NHLBI DNA 重测序和基因分型计划
批准号:
7693490
负责人:
金额:
$39.99万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
首席研究员:塞缪尔·列维博士
英文摘要
PRINCIPAL INVESTIGATOR: Dr. Samuel Levy SUMMARY OF OBJECTIVES: The Center for Advancement in Genomics (TCAG) proposes a state of the art approach to resequence genes and genomic regions based on the application of highly advanced ONA sequencing technology and novel informatics tools. This program will be performed by a highly skilled team from the TCAG, The Institute for Genomic Research (TIGR) and the Joint Technology Center (JTC), Starting with genes and ONA samples selected by the NHLBI, we will optimize the polymerase chain reaction (PCR) to amplify ONA regions 800 bp in length for subsequent capillary based dye-terminator sequencing, Our scientific strategy, aimed toward achieving highly accurate ONA sequencing, uses a tiling strategy that assures two-fold coverage of each nucleotide, and facilitates the use of software for automated polymorphism calls using signal processing approach to sequence traces. In instances where this initial sequencing does not achieve the desired accuracy, additional sequencing reactions will be performed to assure the required quality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
  • 批准号:
    2026JJ80500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    阳帆
  • 依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
  • 批准号:
    2026JJ81975
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖娇
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究